Author:

Adrienne is currently completing her J.D. (2019) at Osgoode Hall Law School. She received her M.A. (2012) and Ph.D. (2016) in Health Policy & Equity with a focus on pharmaceutical policy, regulation, and patient safety.

Archives

March 2018
November 2016
August 2016
July 2015
February 2015
November 2014
September 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
November 2012
May 2012
May 2011
November 2010

Categories

All
Abbott Laboratories
Acne Treatments
Adderall Xr
Adriane Fugh-Berman
Adverse Events
Aggrenox
Alan Cassels
Alltrials Petition
Amgen
Anna Reid
Antidepressants
Apotex
Aranesp Darbepoetin Alfa
Arthur Schafer
Astra Zeneca
Atrovent Ipratropium
Australia
Avandia
Awareness
Barbara Mintzes
Baycol Cerivastatin
Bayer
Bextra Valdecoxib
Birth Control Pills
Birth Defects
Boehringer Ingelheim
Bristolmyers Squibb
British Columbia
Cahspr
Canadas Health Care System
Canadian Centre For Policy Alternatives Ccpa
Chspr
Ciprofloxacin
Clinical Trial Data
College Of Pharmacists
Combivent
Conference
Conflicts Of Interest
Consumer Advocates
Contract Research Organization Cro
Crestor Rosuvastatin
David Healy
Depakote Divalproex Sodium
Diabetes
Diovan Valsartan
Direct To Consumer Advertising Dtca
Direct To Physician Advertising Dtpa
Disease Mongering
Drug Compounding Companies
Drug Coverage In Canada
Drug Manufacturing
Drug Promotion
Drug Safety
Education
Eli Lilly
Elsevier
Erectile Dysfunction Drugs
Ethics Standards
European Medicines Agency
Evidence For Caution
Financial Reward
Food And Drug Administration Fda
Fosamax Alendronate Sodium
France
French National Agency Of Medicine And Health Products Safety Ansm
Geodon
Ghostwriting
Glaxosmithkline Gsk
Gleevec Imatinib
Health Canada
Helsinki Declaration
Hyalgan
India
Interviews
Isotretinoin
Janssen
Japan
Job Cuts
Joel Lexchin
Johnson Johnson
Lescol Fluvastatin
Lipitor Atorvastatin
Liptruzet Atorvastatinezetimibe
Liptruzet Atorvastatin Ezetimibe
Litigation
Lopid Gemfibrozil
Lyrica
Marc Andre Gagnon
Marc A Rodwin
Mediator Benfluorex
Medical Ghostwriting
Medical Journals
Medication Guidelines
Merck
Mevacor Lovastatin
Micardis
Michael Mcbane
Myfortic Mycophenolic Acid
National Institute Of Biological Standards And Control
Neurontin Gabapentin
Novartis
Novo Nordisk
Nsaids
Off Label Prescribing
Open Pharma
Outsourcing
Patient Advocacy
Patient Protection And Affordable Care Act Ppaca
Patient Safety
Paxil
Pfizer
Pharmacare
Pharmaceutical Affairs Law
Pharmaceutical Policy Research Collaboration Pprc
Pharmacists Planning Services Inc
Pharmedout
Physicians
Pradaxa Dabigatran
Pravachol Pravastatin
Prepulsid Cisapride
Prescrire
Professional Medical Associations
Propublica
Protecting Canadians From Unsafe Drugs Act
Ranbaxy
Regeneron Pharmaceutical Inc
Regulation
Research And Development
Research And Development
Rhabdomyolysis
Risperdal Risperidone
Roche
Romanow Report
Royal Canadian Mounted Police Rcmp
Rxiskorg
Sanofi Aventis
Selling Sickness
Seniors
Sergio Sismondo
Seroquel Quetiapin
Shire
South Korea
Statins
Steve Morgan
Steven Lewis
Sun Pharma
Sweden
Tamiflu
Tasigna Nilotinib
Tecfidera Dimethyl Fumarate
Terence Young
Therapeutics Initiative
Trials Tracker
Tylenol Acetaminophen
Uk Medicines And Healthcare Products Regulatory Agency Mhra
Uk National Health Service Nhs
University Of British Columbia
University Of Toronto
Us Centres For Medicare Medicaid
Us Fdasia
Us Sunshine Act
Viagra
Victoza Liraglutide
Vioxx Rofecoxib
Wellbutrin Bupropion
Women
Zocor Simvastatin
Zometa Zoledonic Acid
Zyprexa Olanzapine
Zyvox

RSS Feed